$4.08 2.8%
AVXL Stock Price vs. AI Score (Last 150 days)
Data gathered: June 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Anavex Life Sciences

Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to aging populations (Parkinson's Disease and Alzheimer's Disease) More about us.


Anavex Life Sciences
Price $4.08
Target Price Sign up
Volume 5,790,000
Market Cap $336M
Year Range $3.39 - $9.95
Dividend Yield 0%
Revenue per Employee $191,286
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '241.6M2.8M-1.2M-11M-13M-0.130
Q4 '232.2M2.6M-450,000-8.6M-11M-0.110
Q3 '231.8M2.6M-820,000-10M-10M-0.120
Q2 '231.7M3.2M-1.5M-11M-11M-0.140
Q1 '231.3M2.9M-1.5M-13M-14M-0.170

Insider Transactions View All

Donhauser Peter D.O. filed to buy 5,000 shares at $3.6.
June 17 '24
Thomas Steffen filed to buy 5,000 shares at $4.5.
May 17 '24
MISSLING CHRISTOPHER U filed to sell 1,250,210 shares at $5.1.
April 1 '24
MISSLING CHRISTOPHER U filed to sell 1,018,210 shares at $8.
June 30 '23
Skarpelos Athanasios filed to sell 1,306,458 shares at $9.1.
May 27 '22

Congress Trading View All

Politician Filing Date Type Size
Christopher Jacobs
Republican
Jan 20, 23 Sell $1K - $15K
Christopher Jacobs
Republican
Nov 16, 22 Buy $1K - $15K

What is the Market Cap of Anavex Life Sciences?

The Market Cap of Anavex Life Sciences is $336M.

How Many People Work at Anavex Life Sciences?

As of our latest update, Anavex Life Sciences employed approximately 38 people worldwide. However, it's important to note that Anavex Life Sciences' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Anavex Life Sciences' revenue per employee?

$191,286. To calculate Anavex Life Sciences' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Anavex Life Sciences?

Currently, the price of one share of Anavex Life Sciences stock is $4.08.

How can I analyze the AVXL stock price chart for investment decisions?

The AVXL stock price chart above provides a comprehensive visual representation of Anavex Life Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Anavex Life Sciences shares. Our platform offers an up-to-date AVXL stock price chart, along with technical data analysis and alternative data insights.

Does AVXL offer dividends to its shareholders?

As of our latest update, Anavex Life Sciences (AVXL) does not offer dividends to its shareholders. Investors interested in Anavex Life Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Anavex Life Sciences?

Some of the similar stocks of Anavex Life Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and BridgeBio Pharma.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.